dc.creator | Gatselis, N. K. | en |
dc.creator | Liamis, G. | en |
dc.creator | Makaritsis, K. P. | en |
dc.creator | Dalekos, G. N. | en |
dc.date.accessioned | 2015-11-23T10:27:01Z | |
dc.date.available | 2015-11-23T10:27:01Z | |
dc.date.issued | 2012 | |
dc.identifier | 10.2169/internalmedicine.51.6405 | |
dc.identifier.issn | 0918-2918 | |
dc.identifier.uri | http://hdl.handle.net/11615/27669 | |
dc.description.abstract | Metabolic acidosis is a frequently encountered acid-base disturbance in hospitalized patients that occasionally develops in the course of treatment with medications used in everyday clinical practice, including propylene glycol-containing drugs (lorazepam, diazepam, etomidate, pentobarbital). Disruption of enterohepatic circulation with activated charcoal is a common practice for several intoxications, including mushroom poisoning. Herein, we present a patient who was hospitalized due to mushroom intoxication and developed severe metabolic acidosis as a treatment side effect rather than from the mushroom poisoning..o the best of our knowledge, this is the first report on propylene glycol-containing activated charcoal-induced metabolic acidosis. | en |
dc.source | Internal Medicine | en |
dc.source.uri | <Go to ISI>://WOS:000304604400016 | |
dc.subject | metabolic acidosis | en |
dc.subject | lactate | en |
dc.subject | anion gap | en |
dc.subject | propylene glycol toxicity | en |
dc.subject | charcoal | en |
dc.subject | mushroom poisoning | en |
dc.subject | LACTIC-ACIDOSIS | en |
dc.subject | ANION-GAP | en |
dc.subject | MANAGEMENT | en |
dc.subject | INFUSION | en |
dc.subject | GLYCOL | en |
dc.subject | BASE | en |
dc.subject | Medicine, General & Internal | en |
dc.title | Metabolic Acidosis during Treatment of Mushroom Poisoning: A Diagnostic Pitfall | en |
dc.type | journalArticle | en |